EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genotype‐Dependent Effects of Mechanical Stretch and GATA4‐Targeted Compound 3i‐1262 in Cardiomyopathy Patient–Derived hiPSC‐Cardiomyocytes

Saana Pohjavaara iD, Sini M Kinnunen iD, Heikki Ruskoaho iD, Katriina Aalto-Setälä iD, Mika J Välimäki iD, Virpi Talman iD

Basic & Clinical Pharmacology & Toxicology · 2026

DOI: 10.1111/bcpt.70284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2026. Verfasst von Saana Pohjavaara und 5 weiteren Autor:innen. Beteiligte Einrichtung: Drug Research Program and Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Induced Pluripotent Stem Cells, GATA4 Transcription Factor, Cardiomyopathy, Dilated. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Suomen Kulttuurirahasto, Sydäntutkimussäätiö, Research Council of Finland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genetic hypertrophic and dilated cardiomyopathies (HCM and DCM, respectively) are characterised by structural and functional abnormalities that can lead to heart failure. However, current therapies mainly reduce symptoms. Patient‐derived human induced pluripotent stem cell (hiPSC)–derived cardiomyocytes provide a valuable platform to study genotype‐specific pathophysiology and pharmacology. We subjected hiPSC‐cardiomyocytes from healthy individuals and from patients carrying pathogenic MYBPC3 (HCM) or LMNA (DCM) mutations to cyclic mechanical stretch, with or without the GATA4‐targeted anti‐hypertrophic compound 3i‐1262, and assessed hypertrophy‐associated, mechanosensitive and metabolism‐related genes by qPCR, and hypertrophy‐related proteins by Western blotting. Compared to control, HCM cardiomyocytes displayed higher basal expression of NPPB and MYH7 , whereas DCM cardiomyocytes exhibited lower basal expression of NPPB and NPPA . Mechanical stretching induced NPPB and MYH7 upregulation in control cardiomyocytes, delayed MYH7 upregulation in HCM cardiomyocytes and NPPA downregulation in DCM cardiomyocytes. Other mechanosensitive genes, such as GAL , CSRP3 and SLC16A9 , also exhibited genotype‐ and time‐dependent regulation. In control cardiomyocytes, 3i‐1262 produced limited modulation of stretch‐induced gene expression but showed little or no effect in patient‐derived cardiomyocytes. These findings demonstrate that cardiomyopathy mutations influence gene and protein expression, responses to mechanical stretch and 3i‐1262, underscoring the value of patient‐derived hiPSC‐cardiomyocytes in disease modelling and drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacInduced Pluripotent Stem CellsGATA4 Transcription FactorCardiomyopathy, DilatedCardiomyopathy, HypertrophicHumansGenotypeStress, MechanicalCarrier ProteinsLamin Type AMutationMyosin Binding Protein CMyosin Heavy ChainsCells, CulturedCardiac Myosins

Stichwörter der Autor:innen

GATA4dilated cardiomyopathyhiPSC‐derived cardiomyocyteshypertrophic cardiomyopathymechanical stretch

Substanzen

GATA4 Transcription FactorGATA4 protein, humanCarrier ProteinsLamin Type ALMNA protein, humanMyosin Binding Protein CMyosin Heavy ChainsMYH7 protein, humanCardiac Myosins

Autor:innen und Institutionen

  • Drug Research Program and Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Faculty of Medicine and Health Technology and BioMediTech Institute, Tampere University, Tampere, Finland.
  • Heart Hospital, Tampere University Hospital, Tampere, Finland.
  • Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, Faculty of Medicine, University of Turku, Turku, Finland.

ORCID-Profile: Saana Pohjavaara, Sini M Kinnunen, Heikki Ruskoaho, Katriina Aalto-Setälä, Mika J Välimäki, Virpi Talman

Förderung

  • Suomen Kulttuurirahasto
  • Sydäntutkimussäätiö
  • Research Council of Finland
  • Sigrid Juséliuksen Säätiö

Zitieren

APA

Pohjavaara, S., Kinnunen, S. M., Ruskoaho, H., Aalto-Setälä, K., Välimäki, M. J., & Talman, V. (2026). Genotype‐Dependent Effects of Mechanical Stretch and GATA4‐Targeted Compound 3i‐1262 in Cardiomyopathy Patient–Derived hiPSC‐Cardiomyocytes. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70284

Vancouver

Pohjavaara S, Kinnunen SM, Ruskoaho H, Aalto-Setälä K, Välimäki MJ, Talman V. Genotype‐Dependent Effects of Mechanical Stretch and GATA4‐Targeted Compound 3i‐1262 in Cardiomyopathy Patient–Derived hiPSC‐Cardiomyocytes. Basic & Clinical Pharmacology & Toxicology. 2026. doi:10.1111/bcpt.70284

BibTeX
@article{Pohjavaara2026,
  author = {Pohjavaara, Saana and Kinnunen, Sini M and Ruskoaho, Heikki and Aalto-Setälä, Katriina and Välimäki, Mika J and Talman, Virpi},
  title = {Genotype‐Dependent Effects of Mechanical Stretch and GATA4‐Targeted Compound 3i‐1262 in Cardiomyopathy Patient–Derived hiPSC‐Cardiomyocytes},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2026},
  doi = {10.1111/bcpt.70284}
}
Kostenlos starten →